Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades2,543
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions1
GSK
Media1
GSK Company
Research
GSK Company
Timeline2
Share Price Information for Glaxosmithkline (GSK)
Last checked at -
Last checked at 
Intraday Glaxosmithkline Share Chart
Glaxosmithkline News
LONDON MARKET MIDDAY: Stocks slide but gambling sector sees gains
(Alliance News) - Stock prices in London were drifting lower at midday on Friday, failing to muster much enthusiasm for the latest rise in UK retail s...
LONDON MARKET OPEN: Stocks slip despite UK retail sale boost in July
(Alliance News) - Stock prices in London opened lower on Friday, slipping a little in a quieter end to the week despite positive retail data for July.
GSK to seek dismissal of Zantac Florida case as court rejects testimony
(Sharecast News) - UK pharma giant GSK has welcomed a US court ruling excluding expert testimony in the long-running Zantac lawsuit where the plaintif...
TOP NEWS: GSK celebrates Florida state court ruling in Zantac case
(Alliance News) - GSK PLC on Thursday welcomed a court ruling in Florida state court that found in the drug makers favour.
UK dividends calendar - next 7 days
German panel endorses GSK, Pfizer RSV vaccines for elderly
FRANKFURT, Aug 8 (Reuters) - Germany's influential vaccine advisory panel said on Thursday that everyone in the country who is 75-years old or more ...
Third trial over Zantac cancer claims ends with hung jury
Aug 7 (Reuters) - The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree a...
Third trial over Zantac cancer claims ends with hung jury
Aug 7 (Reuters) - The third trial over claims that discontinued heartburn drug Zantac ended in a mistrial on Wednesday when jurors could not agree a...
Follow the stocks
